| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 25 | 25 | 30 | 28 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 25 | 25 | 30 | 28 | | | Operating Expenses | | Research Development | 16,494 | 13,322 | 11,797 | 10,755 | | Selling General and Administrative | 9,301 | 7,608 | 5,217 | 4,783 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (25,770) | (20,905) | (16,984) | (15,510) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (19,175) | (105,600) | 2,712 | 7,834 | | Earnings Before Interest And Taxes | (44,945) | (126,505) | (14,272) | (7,676) | | Interest Expense | 606 | 212 | 1,112 | 1,161 | | Income Before Tax | (45,551) | (126,717) | (15,384) | (8,837) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (45,551) | (126,717) | (15,384) | (8,837) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (45,551) | (126,717) | (15,384) | (8,837) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($45,551) | ($126,717) | ($15,384) | ($8,837) |
|
0.11% Nasdaq 
0.29%
Income Statement
